Dr. S. Goffette

  • Citations Per Year
Learn More
Mitoxantrone is an approved drug for patients with worsening relapsing–remitting, secondary progressive and progressive relapsing multiple sclerosis (MS). From a cohort of 820 MS patients, 52 (6%) were treated with this drug between December 1991 and April 2003. Mitoxantrone was administered at a dose of 12 mg/m2 once a month for three months and then at(More)
  • 1